Enanta Pharmaceuticals (ENTA) PT Lowered to $15 at RBC Capital Oct 2, 2023 06:26AM
Enanta Pharmaceuticals to Participate in Two Investor Conferences in May May 9, 2023 07:00AM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET May 8, 2023 04:01PM
Enanta Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference May 11, 2021 07:00AM
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET May 6, 2021 04:01PM


May 12, 2020 07:30AM Enanta Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
May 6, 2020 04:03PM Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET
Aug 7, 2019 06:54AM Enanta Pharmaceuticals (ENTA) PT Lowered to $88 at RBC Capital
Jun 14, 2019 06:54AM Enanta Pharmaceuticals (ENTA) PT Raised to $98 at RBC Capital
May 14, 2019 04:01PM Enanta Pharmaceuticals to Present at Upcoming Investor Conference
May 8, 2019 06:51AM Enanta Pharmaceuticals (ENTA) PT Lowered to $94 at RBC Capital
May 7, 2019 04:00PM Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2019
Feb 7, 2019 06:34AM Enanta Pharmaceuticals (ENTA) PT Raised to $89 at RBC Capital
Nov 28, 2018 06:36AM Enanta Pharmaceuticals (ENTA) PT Lowered to $85 at RBC Capital
Aug 8, 2018 08:33AM Enanta Pharmaceuticals (ENTA) PT Lowered to $90 at RBC Capital
Aug 7, 2018 10:34AM Formulary Update a Net Positive for Gilead Sciences (GILD), Negative for Enanta (ENTA) - RBC
May 9, 2018 11:27AM Enanta Pharmaceuticals (ENTA) PT Raised to $100 at RBC Capital
Feb 12, 2018 07:30AM Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 7, 2018 04:01PM Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017
Jan 2, 2018 03:40AM RBC Capital Downgrades Enanta Pharmaceuticals (ENTA) to Sector Perform, 'Stock Now Better Reflects HCV Royalty Growth and Pipeline Prospects'
Sep 14, 2017 04:50PM RBC Capital Starts Enanta Pharmaceuticals (ENTA) at Outperform
Feb 8, 2017 04:02PM Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2016
Feb 6, 2017 04:01PM Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences